Milnacipran Impurity 4, identified by its CAS number 1353644-49-1, is a chemical compound that is typically associated with the synthesis and quality control of the antidepressant milnacipran, which is primarily used to treat fibromyalgia and major depressive disorder. As an impurity, it may arise during the manufacturing process and can affect the purity and efficacy of the final pharmaceutical product. The characteristics of Milnacipran Impurity 4 include its molecular structure, which is likely to be similar to that of milnacipran, featuring functional groups that may influence its solubility and reactivity. Impurities like this are often analyzed using techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry to ensure compliance with regulatory standards. Understanding the properties of such impurities is crucial for pharmaceutical development, as they can impact the safety, efficacy, and stability of the drug formulation. Proper characterization and quantification are essential for maintaining the quality of pharmaceutical products.

Milnacipran Impurity 4

1353644-49-1: Milnacipran Impurity 4, identified by its CAS number 1353644-49-1, is a chemical compound that is typically associated with the synthesis and quality control of the antidepressant milnacipran, which is primarily used to treat fibromyalgia and major depressive disorder. As an impurity, it may arise during the manufacturing process and can affect the purity and efficacy of the final pharmaceutical product. The characteristics of Milnacipran Impurity 4 include its molecular structure, which is likely to be similar to that of milnacipran, featuring functional groups that may influence its solubility and reactivity. Impurities like this are often analyzed using techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry to ensure compliance with regulatory standards. Understanding the properties of such impurities is crucial for pharmaceutical development, as they can impact the safety, efficacy, and stability of the drug formulation. Proper characterization and quantification are essential for maintaining the quality of pharmaceutical products.

CAS 1353644-49-1

Milnacipran Impurity 4

Milnacipran Impurity 2

Ref: 4Z-M-4114

Milnacipran Impurity 7

Ref: ST-EA-CP-M47009